Literature DB >> 10781433

In vitro cellular effects of perfluorochemicals correlate with their lipid solubility.

V V Obraztsov1, G G Neslund, E S Kornbrust, S F Flaim, C M Woods.   

Abstract

Preclinical studies comparing perflubron partial liquid ventilation with conventional mechanical ventilation have indicated that perflubron partial liquid ventilation may exert some anti-inflammatory effects. To assess whether these effects were related to the lipid solubility properties of perflubron rather than to nonspecific biophysical properties of the perfluorocarbon (PFC) liquid phase, we studied the effects of PFCs with varying lipid solubilities on the platelet aggregation response to various procoagulants and the erythrocyte hemolytic response to osmotic stress. In both cases, the degree of the response was directly related to the lipid solubility of the PFC. All the perflubron content of erythrocytes was found to be associated with the membrane compartment. The time to reach a maximum effect on hemolysis with perflubron was relatively slow (2-4 h), which paralleled the time for perflubron to accumulate in erythrocyte membranes. The rate and extent of perflubron partitioning into lecithin liposomes were similar to those of erythrocyte membranes, supporting the hypothesis that perflubron was partitioning into the lipid component of the membranes. Thus some of the potential modulatory effects of perflubron on excessive inflammatory responses that occur during acute lung injury and acute respiratory distress syndrome may be influenced in part by the extent of PFC partitioning into the lipid bilayers of cellular membranes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10781433     DOI: 10.1152/ajplung.2000.278.5.L1018

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  10 in total

1.  Lamellar body ultrastructure revisited: high-pressure freezing and cryo-electron microscopy of vitreous sections.

Authors:  Dimitri Vanhecke; Gudrun Herrmann; Werner Graber; Therese Hillmann-Marti; Christian Mühlfeld; Daniel Studer; Matthias Ochs
Journal:  Histochem Cell Biol       Date:  2010-09-01       Impact factor: 4.304

2.  Effect of N-Perfluorooctane on Hypoxia/Reoxygenation Injury in Human Umbilical Vein Endothelial Cells.

Authors:  Jing Jiang; Deng-Yong Chen; Zhi-Tao Liu; Feng Chen; Jing-Jing Zhang; Jing Cui; Jien Pang
Journal:  Acta Cardiol Sin       Date:  2016-11       Impact factor: 2.672

3.  Effects of perfluorocarbons on surfactant exocytosis and membrane properties in isolated alveolar type II cells.

Authors:  Andreas Wemhöner; Irmgard Hackspiel; Nina Hobi; Andrea Ravasio; Thomas Haller; Mario Rüdiger
Journal:  Respir Res       Date:  2010-05-09

4.  High vapor pressure perfluorocarbons cause vesicle fusion and changes in membrane packing.

Authors:  Berenice Venegas; Marla R Wolfson; Peter H Cooke; Parkson Lee-Gau Chong
Journal:  Biophys J       Date:  2008-08-08       Impact factor: 4.033

5.  Perfluorochemical liquid-adenovirus suspensions enhance gene delivery to the distal lung.

Authors:  Jeffrey A Kazzaz; Marlene S Strayer; Jichuan Wu; Daniel J Malone; Hshi-Chi Koo; Thomas H Shaffer; Jonathan M Davis; David S Strayer; Marla R Wolfson
Journal:  Pulm Med       Date:  2011-08-18

6.  Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease.

Authors:  Philipp Steven; Albert J Augustin; Gerd Geerling; Thomas Kaercher; Florian Kretz; Kathleen Kunert; Johannes Menzel-Severing; Norbert Schrage; Wolfgang Schrems; Sonja Krösser; Michael Beckert; Elisabeth M Messmer
Journal:  J Ocul Pharmacol Ther       Date:  2017-09-18       Impact factor: 2.671

7.  Systemic administration of FC-77 dampens ischemia-reperfusion-induced acute lung injury in rats.

Authors:  Shi-Jye Chu; Kun-Lun Huang; Shu-Yu Wu; Fu-Chang Ko; Geng-Chin Wu; Rui-Ying Li; Min-Hui Li
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

8.  Combination Nanotherapeutics for Dry Eye Disease Treatment in a Rabbit Model.

Authors:  Liandi Huang; Huanhuan Gao; Zhigang Wang; Yixin Zhong; Lan Hao; Zhiyu Du
Journal:  Int J Nanomedicine       Date:  2021-05-26

9.  Alterations of alveolar type II cells and intraalveolar surfactant after bronchoalveolar lavage and perfluorocarbon ventilation. An electron microscopical and stereological study in the rat lung.

Authors:  Mario Rüdiger; Sebastian Wendt; Lars Köthe; Wolfram Burkhardt; Roland R Wauer; Matthias Ochs
Journal:  Respir Res       Date:  2007-06-05

Review 10.  Perfluorocarbon-based oxygen carriers: from physics to physiology.

Authors:  Johannes Jägers; Anna Wrobeln; Katja B Ferenz
Journal:  Pflugers Arch       Date:  2020-11-03       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.